Wei Xie Selected Research

Wei Xie Research Topics

Disease

108	Neoplasms (Cancer) 10/2022 - 02/2003
22	Carcinogenesis 01/2022 - 02/2003
20	Infections 10/2022 - 02/2007
19	Atherosclerosis 12/2022 - 01/2014
16	Neoplasm Metastasis (Metastasis) 10/2022 - 02/2003
16	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 11/2005
15	Breast Neoplasms (Breast Cancer) 10/2022 - 04/2004
13	Inflammation (Inflammations) 01/2022 - 11/2010
11	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 10/2014
11	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2010
9	Hypoxia (Hypoxemia) 01/2022 - 11/2003
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2016
8	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 05/2014
7	Liver Neoplasms (Liver Cancer) 02/2022 - 01/2005
7	COVID-19 01/2022 - 01/2021
7	Carcinoma (Carcinomatosis) 12/2018 - 03/2003
6	Autistic Disorder (Autism) 10/2022 - 09/2013
6	Epilepsy (Aura) 01/2021 - 12/2004
6	Cognitive Dysfunction 01/2021 - 10/2012
5	Pathologic Processes 10/2021 - 05/2014
5	Necrosis 10/2021 - 01/2018
5	Seizures (Absence Seizure) 02/2021 - 12/2004
5	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 02/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2010
5	Stomach Neoplasms (Stomach Cancer) 12/2018 - 06/2005
4	Migraine Disorders (Migraine) 06/2022 - 02/2015
4	Intervertebral Disc Displacement (Herniated Disc) 02/2022 - 10/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
4	Myocardial Infarction 01/2022 - 12/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2017
4	Leukemia 12/2021 - 01/2009
4	Triple Negative Breast Neoplasms 01/2021 - 01/2018
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 01/2012
4	Insulin Resistance 10/2019 - 04/2016
4	Disease Progression 01/2019 - 05/2014
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 01/2009
3	Hyperalgesia 06/2022 - 06/2015
3	Pain (Aches) 02/2022 - 09/2016
3	Hypertension (High Blood Pressure) 02/2022 - 11/2008
3	Obesity 01/2022 - 01/2017
3	Lymphoma (Lymphomas) 01/2022 - 01/2020
3	Osteoarthritis 01/2022 - 01/2014

Drug/Important Bio-Agent (IBA)

53	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2005
19	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2014
18	Pharmaceutical PreparationsIBA 07/2021 - 08/2004
14	LipidsIBA 12/2022 - 09/2007
13	AntigensIBA 05/2022 - 02/2003
13	MicroRNAs (MicroRNA)IBA 05/2022 - 05/2014
12	CytokinesIBA 05/2022 - 02/2003
12	Messenger RNA (mRNA)IBA 01/2022 - 03/2003
8	Phosphotransferases (Kinase)IBA 01/2022 - 01/2016
8	Estrogens (Estrogen)FDA Link 01/2021 - 04/2004
8	Therapeutic UsesIBA 01/2021 - 12/2004
8	LigandsIBA 01/2021 - 01/2016
7	Apolipoproteins E (ApoE)IBA 12/2022 - 01/2014
7	Long Noncoding RNAIBA 12/2022 - 04/2016
7	EnzymesIBA 10/2022 - 03/2014
7	Biological ProductsIBA 02/2022 - 03/2003
7	CholesterolIBA 01/2022 - 08/2014
7	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2006
7	Indicators and Reagents (Reagents)IBA 07/2021 - 04/2011
7	Monoclonal AntibodiesIBA 01/2021 - 06/2005
7	ApolipoproteinsIBA 10/2019 - 01/2014
6	Peptides (Polypeptides)IBA 02/2022 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2016
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2011
6	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2017
6	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2007
5	NeuroliginsIBA 10/2022 - 09/2013
5	CateninsIBA 01/2021 - 12/2015
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2015
5	VaccinesIBA 01/2021 - 01/2016
5	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2014
5	Interleukin-17 (Interleukin 17)IBA 11/2020 - 09/2010
5	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2019 - 11/2014
5	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2019 - 01/2014
5	CurcuminIBA 01/2018 - 10/2014
5	SmokeIBA 01/2018 - 01/2015
5	micaIBA 01/2017 - 01/2015
5	HLA Antigens (Human Leukocyte Antigens)IBA 06/2013 - 06/2005
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2016
4	AlbuminsIBA 01/2022 - 07/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2007
4	MethyltransferasesIBA 12/2020 - 11/2007
4	ErbB Receptors (EGF Receptor)IBA 12/2020 - 01/2016
4	Immunoglobulin G (IgG)IBA 06/2017 - 01/2005
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2016 - 01/2016
3	Histones (Histone)IBA 12/2022 - 08/2008
3	Caspase 3 (Caspase-3)IBA 10/2022 - 05/2016
3	IronIBA 05/2022 - 10/2019
3	Circular RNAIBA 05/2022 - 01/2020
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 08/2015
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 05/2015
3	NucleotidesIBA 01/2022 - 03/2012
3	ChromatinIBA 01/2022 - 10/2020

Therapy/Procedure

45	Therapeutics 01/2022 - 11/2003
10	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
9	Immunotherapy 05/2022 - 02/2003
4	Chemoprevention 08/2017 - 10/2009
3	Diskectomy (Discectomy) 02/2022 - 01/2021